RecruitingNCT07748572

PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France

CEFloW (Clinical Experience With Flow Diverter With and Without Movable Wire)

Sponsor

Phenox GmbH

Enrollment

200 participants

Start Date

Mar 7, 2025

Study Type

OBSERVATIONAL

Conditions

Intracranial Aneurysms

Summary

To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Aneurysm treatment with a Flow Modulation Device for people with intracranial aneurysms. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAneurysm treatment with a Flow Modulation Device

Treatment of an intracranial aneurysm (anterior and posterior circulation) with a p64, p48 MW, or p64 MW Flow Modulation Device.

Locations(11)

CHU Amiens-Picardie

Amiens, France

CHU Bordeaux

Bordeaux, France

CHU Pierre Wertheimer

Bron, France

CHU Clermont-Ferrand

Clermont-Ferrand, France

Hôpital Bicêtre

Le Kremlin-Bicêtre, France

CHU de Limoges

Limoges, France

Hôpital Pitié-Salpêtrière

Paris, France

CHU Reims

Reims, France

CHU Rouen

Rouen, France

CHRU Strasbourg

Strasbourg, France

CHU Tours

Tours, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07748572

Related Trials

Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes

NCT076740041 location

NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization

NCT072461481 location

Targeting Real World Usage In Stroke Treatment

NCT0747493513 locations

Post-Market Product Surveillance of Intracranial ANeurysms Treated With Commercial ReGistered ACANDIS Devices in FrancE

NCT069409341 location